As an antiepileptic drug, the side effects of Ospolot involve various aspects such as the nervous system and metabolic system. Targeted relief measures should be taken, and special storage conditions should be noted to maintain drug stability. The following provides a detailed explanation from three aspects: the manifestation of side effects, mitigation methods, and storage requirements.

1. Common side effects and alleviation

(1) About 30% of patients with the nervous system experience drowsiness or dizziness, which often occurs in the early stages of medication. It is recommended to take medication before bedtime and avoid sudden changes in position. Tolerance usually improves after 2-4 weeks.

(2) 15% of patients with digestive system experience nausea and vomiting, which can be reduced by 50% when taken with food. Persistent symptoms can be considered by administering medication in divided doses or using antiemetic drugs.

2. Treatment of serious side effects

(3) The incidence of hyponatremia is about 5%, manifested as blurred consciousness or convulsions. Monthly monitoring of blood sodium is required. If it falls below 125mmol/L, medication should be stopped immediately and water intake should be restricted.

(4) When allergic reactions occur and rash or facial swelling occurs, the medication should be permanently discontinued. The risk of cross allergy exists among users of other sulfonamide drugs.

3 Side effects for special populations

(5) Elderly patients are more prone to gait instability and a two-fold increase in the risk of falls. Suggest halving the initial dose and regularly evaluating balance function.

(6) Child patients may exhibit aggressive behavior or decreased attention, and close monitoring of school performance and behavioral changes is necessary.

4 Storage methods

(7) Temperature control: The original packaging should be stored in an environment of 20-25 ℃, and short-term carrying is allowed to fluctuate between 15-30 ℃. Avoid freezing or high temperature environments.

(8) Moisture proof measures: Aluminum plastic blister packaging should be kept dry and discarded if not used within 6 months after opening.